Replacement of surfactant in hyaline membrane disease.
作者信息
Walters D V
出版信息
Br Med J (Clin Res Ed). 1984 Oct 6;289(6449):855-7. doi: 10.1136/bmj.289.6449.855.
Abstract
摘要
相似文献
1
Replacement of surfactant in hyaline membrane disease.透明膜病中表面活性剂的替代
Br Med J (Clin Res Ed). 1984 Oct 6;289(6449):855-7. doi: 10.1136/bmj.289.6449.855.
2
Artificial surfactant therapy for hyaline membrane disease.用于治疗透明膜病的人工表面活性剂疗法。
Arch Dis Child. 1980 Oct;55(10):753-4. doi: 10.1136/adc.55.10.753.
3
Replacement of surfactant in hyaline membrane disease.透明膜病中表面活性物质的替代疗法。
Br Med J (Clin Res Ed). 1984 Nov 17;289(6455):1381-2. doi: 10.1136/bmj.289.6455.1381-c.
4
[Study of treatment of hyaline membrane disease with pulmonary surfactant replacement in premature infant].
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Apr;19(4):248.
5
Surfactant replacement therapy in newborns with hyaline membrane disease.新生儿透明膜病的表面活性剂替代疗法。
Crit Care Nurs Clin North Am. 1992 Sep;4(3):515-20.
6
The effectiveness and cost of exogenous pulmonary surfactant replacement therapy.外源性肺表面活性物质替代疗法的有效性和成本。
S Afr Med J. 1995 Nov;85(11):1192, 1195-6.
7
[Administration of surfactant in hyaline membrane disease].[透明膜病中表面活性剂的应用]
An Esp Pediatr. 1987 Sep;27(3):147-51.
8
Neonatal surfactant replacement therapy. Fetus and Newborn Committee, Canadian Paediatric Society.新生儿表面活性剂替代疗法。加拿大儿科学会胎儿与新生儿委员会。
CMAJ. 1992 Apr 15;146(8):1309-12.
9
Surfactant replacement therapy.表面活性剂替代疗法。
Thorax. 1996 Nov;51(11):1137-54. doi: 10.1136/thx.51.11.1137.
10
A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.表面活性剂治疗对透明膜病气体交换影响的模型
Semin Perinatol. 1994 Feb;18(1):19-22.
本文引用的文献
1
2
Bronchiolar epithelial lesions induced in the premature rabbit neonate by short periods of artificial ventilation.
Acta Pathol Microbiol Scand A. 1980 Nov;88(6):359-67. doi: 10.1111/j.1699-0463.1980.tb02507.x.
3
Increased shunt through the patent ductus arteriosus after surfactant replacement therapy.表面活性剂替代疗法后动脉导管未闭导致的分流增加。
J Pediatr. 1982 Jan;100(1):101-7. doi: 10.1016/s0022-3476(82)80247-3.
4
Path dependence of adsorption behavior of mixtures containing dipalmitoyl phosphatidylcholine.含二棕榈酰磷脂酰胆碱混合物吸附行为的路径依赖性
Pediatr Res. 1982 Jul;16(7):515-9. doi: 10.1203/00006450-198207000-00003.
5
What is the true role of surfactant in the lung?表面活性剂在肺部的真正作用是什么？
Thorax. 1981 Jan;36(1):1-4. doi: 10.1136/thx.36.1.1.
6
Surface activity following natural surfactant treatment in premature lambs.
J Appl Physiol Respir Environ Exerc Physiol. 1981 Aug;51(2):306-12. doi: 10.1152/jappl.1981.51.2.306.
7
Effect of lipids and other substances on the adsorption of dipalmitoyl phosphatidylcholine.
Pediatr Res. 1981 Jul;15(7):1029-31. doi: 10.1203/00006450-198107000-00010.
8
The quantity of natural surfactant necessary to prevent the respiratory distress syndrome in premature lambs.
Pediatr Res. 1980 Sep;14(9):1082-5. doi: 10.1203/00006450-198009000-00013.
9
Surfactant substitution; experimental models and clinical applications.表面活性剂替代疗法；实验模型与临床应用。
Lung. 1980;158(2):57-68. doi: 10.1007/BF02713705.
10
Pulmonary surfactant-associated proteins: their role in the expression of surface activity.肺表面活性物质相关蛋白：它们在表面活性表达中的作用。
J Appl Physiol Respir Environ Exerc Physiol. 1980 Jul;49(1):34-41. doi: 10.1152/jappl.1980.49.1.34.
Zotero 插件